Knee Pain

Clinically reviewed Aug 29, 2026 Updated Aug 30, 2026

Clinical Snapshot

Knee pain is one of the most common musculoskeletal complaints seen in primary care and community pharmacy, and it presents an unusually broad differential for a single-joint symptom — in Alberta alone, more than half a million people sought physician services for a knee-related issue in the 2018-2019 fiscal year.[1] The knee has the largest articulating surface of any joint in the body and is a major weight-bearing joint, which is part of why it is injured and degenerates so often, and why its pain can arise from so many distinct structures.[1]

This chapter is a practical, pharmacist-focused triage and OTC/topical self-care framework for the full range of knee pain causes, organized around distinguishing likely-benign, self-manageable presentations from those needing prompt medical evaluation. It is explicitly complementary to, not a replacement for, four other chapters in this library: the Osteoarthritis chapter for the full evidence-based management of degenerative knee disease (the single most common underlying cause of chronic knee pain); the Sports Injuries chapter for acute soft-tissue injury grading and the modern POLICE-based approach to acute ligament sprains and muscle strains; and the Bursitis and Gout and Hyperuricemia chapters for those two specific conditions when the knee is the affected site. This chapter instead focuses on the practical categories a pharmacist needs to sort a knee-pain presentation into, the findings that separate them, and the evidence for topical and oral OTC pain relief — including patellofemoral pain syndrome, which is covered here in full since no other chapter in this library addresses it.

Anatomical illustration of the right knee joint, anterior view, showing the patella, femur, tibia, fibula, and the major ligaments of the knee
The knee joint (anterior view) — the largest articulating surface in the body, spanning bone, cartilage, the menisci, four major ligaments, and the patellofemoral joint, any of which can be a source of knee pain. (Henry Vandyke Carter, illustrator, in Henry Gray, Anatomy of the Human Body, 20th ed., 1918; public domain, Wikimedia Commons)

Recognize the Condition

A practical six-category framework

Knee pain can be sorted into six broad, practical categories for triage purposes. These overlap in practice — a degenerative meniscal tear and early medial compartment osteoarthritis often coexist — but each has a reasonably distinct typical presentation.[1]

1. Degenerative (osteoarthritis)

By far the most common cause of chronic knee pain, typically affecting adults over 50, with pain that worsens with activity and stiffness that is most pronounced after a period of inactivity. Pain is usually diffuse around the affected joint line rather than sharply localized, and an effusion is common during a flare, though ligaments remain stable.[1] This chapter covers only triage-level recognition; for the full evidence-based approach to diagnosis, exercise and weight-management therapy, NSAID selection, injection, and referral for joint replacement, see the platform's Osteoarthritis chapter.

2. Acute traumatic injury — ligament sprain and meniscal tear

A discrete traumatic event — a twisting injury with the foot planted, a direct blow, or a non-contact pivoting injury during sport — points toward an acute ligament sprain or meniscal tear rather than a degenerative or overuse process. Two historical clues matter most: true locking (a genuine mechanical block to full extension or flexion, distinct from ordinary stiffness or clicking, suggesting a meniscal tear or loose body) and true giving way (a sensation of the knee buckling or being untrustworthy, suggesting ligamentous instability, classically from an ACL injury).[1] Rapid swelling, bruising, or redness within hours of an injury suggests significant intra-articular tissue damage, such as an ACL tear, rather than a simple sprain.[1] This chapter covers only the acute-injury red flags and the Ottawa Knee Rule for imaging; for full injury grading, the current POLICE-based approach, and analgesic selection, see the platform's Sports Injuries chapter.

3. Patellofemoral pain syndrome

Patellofemoral pain syndrome (PFPS, sometimes imprecisely called "runner's knee") is an extremely common cause of knee pain, especially in younger and more active patients, and — unlike the other categories — is covered here in full. It is defined as pain occurring around or behind the patella that is reproducibly aggravated by at least one activity that loads the patellofemoral joint during weight-bearing on a flexed knee.[2] It affects an estimated 3-6% of the U.S. population, most often adolescents and adults younger than 60, with a modest female predominance (about 55% of cases).[2] Unlike chondromalacia patellae, which involves a visible structural cartilage defect, PFPS by definition shows no such abnormality — it is a diagnosis based on the pain pattern, not on imaging.[2]

Classic aggravating activities load the patellofemoral joint with the knee flexed: running, climbing and especially descending stairs, squatting, kneeling, and prolonged sitting with the knee bent.[2][1] On examination, pain reproduced by squatting is the single most sensitive finding (91% sensitivity), and a positive patellar tilt test carries the highest positive likelihood ratio (5.4) among individual exam maneuvers; hip abductor and external rotator weakness is common and clinically relevant, since it is a specific target of first-line exercise therapy.[2] Knee range of motion is normal, and imaging is not required for a typical presentation.[2][1]

4. Knee bursitis

Prepatellar bursitis ("housemaid's knee") — inflammation of the bursa anterior to the patella — classically follows repetitive kneeling, presenting as localized swelling and tenderness directly over or just below the kneecap, usually without significant loss of range of motion.[1] Pes anserine bursitis, at the anserine insertion just distal to the medial joint line, is associated with repetitive valgus strain and is more common with genu valgum.[1] This chapter covers only these knee-specific recognition points; for the full anatomy, the essential septic-versus-aseptic distinction, and management, see the platform's Bursitis chapter.

5. Gout (and other crystal/inflammatory arthritis)

Gout is an important and frequently underrecognized cause of acute monoarticular knee pain and swelling — while podagra (first metatarsophalangeal involvement) is the classic presentation, the knee is also commonly affected, and a knee gout flare can look clinically similar to septic arthritis, which is exactly why the distinction is treated as a specific red flag below.[3] This chapter covers only that acute recognition point; for the four clinical stages of gout, acute-flare therapy, and treat-to-target urate-lowering therapy, see the platform's Gout and Hyperuricemia chapter.

6. Overuse and tendinopathy patterns

Quadriceps and patellar tendinopathy present with activity-related pain, typically gradual in onset without a specific traumatic event, worsened by explosive movements such as jumping, sprinting, and resisted knee extension; tenderness is felt directly over the involved tendon, which may feel thickened, and range of motion is normal.[1] Iliotibial band (ITB) syndrome causes insidious-onset lateral knee pain that increases with overuse, classically in runners and cyclists, felt over the lateral femoral condyle and often associated with weak hip abduction.[1] Both patterns respond to the activity-modification-and-structured-exercise approach in Non-Pharmacologic Management, and neither requires imaging for a typical presentation.

Risk Factors

  • Age over 50 — the dominant risk factor for degenerative knee osteoarthritis; see the Osteoarthritis chapter for the full risk-factor profile.[1]
  • Participation in pivoting, cutting, or jumping sports (basketball, soccer, skiing, volleyball) — the classic mechanism for an acute ACL tear or meniscal injury; see the Sports Injuries chapter.
  • Adolescent/young-adult age and female sex — the classic demographic for patellofemoral pain syndrome, along with hip abductor/external rotator weakness, quadriceps weakness, and training errors (a rapid increase in running volume or intensity).[2]
  • Genu valgum ("knock knees") — a specific risk factor for pes anserine bursitis and lateral compartment loading; genu varum ("bow legs") predisposes to medial compartment loading and osteoarthritis.[1]
  • Occupations or hobbies involving repetitive or sustained kneeling (flooring, carpet-laying, gardening, religious practice) — the classic risk factor for prepatellar bursitis; see the Bursitis chapter.
  • Obesity — increases mechanical load across the knee with every step, a specific and modifiable risk factor for osteoarthritis and patellofemoral pain alike; each pound of body weight lost produces roughly a four-fold reduction in the load exerted across the knee per step during daily activities.[1]
  • Prior knee injury or surgery — raises suspicion for reinjury or accelerated secondary osteoarthritis and should specifically be asked about.[1]
  • Hyperuricemia, obesity, a high-purine diet, alcohol use, and loop/thiazide diuretic use — risk factors for a gout flare; see the Gout and Hyperuricemia chapter.[3]
  • Training errors and overuse (a sudden increase in running distance, hill or stair training, worn or inappropriate footwear) — the common final pathway to quadriceps/patellar tendinopathy and iliotibial band syndrome.
  • Comorbidities worth noting during history-taking — obesity (BMI), smoking, and glycemic control (HbA1c) all affect both the differential and the management plan.[1]

Red Flags & Refer

Knee pain has an unusually broad differential for a single-joint complaint, and the pharmacist's central task is recognizing the findings below — not making a definitive diagnosis:

  • Inability to bear weight, or significant instability ("true giving way") — suggests a ligament tear (especially ACL) or a displaced meniscal tear and needs prompt medical evaluation rather than OTC self-care.[1]
  • A hot, swollen, and acutely painful knee — raises concern for either septic arthritis or an acute gout (or pseudogout) flare, and this distinction genuinely matters: septic arthritis is a joint-threatening and life-threatening emergency, with reported mortality of 10-20% and a real risk of irreversible cartilage destruction if treatment is delayed, while gout, though also acutely painful, is not a surgical or infectious emergency.[3] Fever, marked erythema extending beyond the joint margin, and systemic illness favour infection, but fever should not be relied upon to exclude septic arthritis, since it is not always present. A rapid-onset, nocturnal-predominant flare with a history of prior similar episodes, hyperuricemia, or diuretic/alcohol use favours gout — but because the two can look genuinely similar at the bedside, any acutely hot, swollen, and significantly painful knee needs prompt medical assessment (including likely joint aspiration) rather than empiric OTC treatment for presumed gout.[3]
  • Significant trauma with suspected fracture — apply the Ottawa Knee Rule, a Canadian-derived and validated clinical decision rule, as a mental checklist for whether radiography is warranted: age 55 years or older, isolated tenderness of the patella (no other bony tenderness), tenderness at the head of the fibula, inability to flex the knee to 90 degrees, or inability to bear weight for four steps both immediately after the injury and at assessment. Any one of these five findings is reason to refer for x-ray; the rule is highly sensitive (approaching 100%) for a clinically important fracture, meaningfully reducing unnecessary radiography in patients who meet none of the criteria.[4]
  • Any knee pain with systemic symptoms — fever, night sweats, unintentional weight loss, or pain unrelated to activity, worse at night, and not relieved by rest — should prompt referral to rule out infection or, rarely, malignancy, rather than assuming a mechanical or degenerative cause.[1]
  • Neurovascular compromise — a rapid change in sensation, or reduced/absent distal pulses — needs emergency assessment.[1]
  • True locking (a genuine mechanical block preventing full extension or flexion) — suggests a displaced meniscal tear or loose body and warrants referral rather than a trial of self-care.[1]
  • Multi-joint involvement, or knee symptoms without a history of trauma or overuse — broadens the differential to an inflammatory or crystal arthropathy and warrants medical work-up rather than an assumed mechanical cause.[1]

Assessment & Diagnosis

The pharmacist's role: red-flag screening and OTC-appropriateness, not definitive diagnosis

A pharmacist cannot and should not attempt to definitively diagnose the specific structural cause of knee pain — that requires a directed physical examination with special tests (McMurray's, Lachman, anterior/posterior drawer, varus/valgus stress testing) outside pharmacist scope of practice in most jurisdictions. The pharmacist-level assessment instead focuses on two practical questions: does this presentation contain a red flag that changes the plan from OTC self-care to medical referral, and, if not, which of the six categories above does the pattern most resemble — so that OTC/topical therapy and self-care advice can be targeted rather than generic.

A structured history

Ask about: age, sex, and occupation (a work-related injury may change the recommended pathway); onset — acute (under 6 weeks) versus chronic (over 6 weeks), sudden versus gradual, traumatic versus non-traumatic; the primary concern (pain, instability, swelling, or a mechanical symptom such as clicking, catching, or locking); pain location, radiation, and aggravating/alleviating factors — constant pain suggests a more active inflammatory process, while intermittent, activity-related pain points more toward mechanical/overuse causes, and night pain is more suggestive of bony or joint pathology; any previous knee injury, surgery, imaging, or treatment; and specifically, true locking versus simple clicking/stiffness, true giving way versus a vague sense of weakness, and any rapid swelling, bruising, or redness following an injury.[1]

A structured, pharmacist-appropriate examination

Observe gait; look for redness, swelling, warmth, or signs of infection; and, if comfortable and within scope, palpate for the location of maximal tenderness (patella, quadriceps tendon, pes anserine, joint lines) and compare active range of motion with the unaffected side. Anything beyond this — special ligament and meniscal tests, or aspiration — is outside pharmacist scope and should prompt referral to a physician, physiotherapist, or emergency department as clinically indicated.[1]

Differential diagnosis by anatomic location

LocationCommon causes
Anterior knee painPatellofemoral pain syndrome, chondromalacia patella, quadriceps/patellar tendinopathy, prepatellar bursitis, Osgood-Schlatter disease (pediatric), chronic patellar subluxation/dislocation
Intra-articularOsteoarthritis, unstable meniscal tear, osteochondral defect, osteochondritis dissecans (children/adolescents), spontaneous osteonecrosis of the knee
Medial knee painMedial meniscal injury (acute or degenerative), medial compartment osteoarthritis, pes anserine bursitis, MCL sprain
Lateral knee painIliotibial band syndrome, lateral meniscal injury, lateral compartment osteoarthritis, LCL sprain
Posterior knee painBaker's (popliteal) cyst, gastrocnemius strain, PCL sprain
Instability, with or without painACL or PCL tear, high-grade MCL/LCL sprain, unstable meniscal tear, patellar instability, intra-articular loose body

[1]

Imaging and referral thresholds

Most knee pain, and particularly degenerative knee pain, does not need imaging for initial management.[5] Don't order a knee MRI when weight-bearing x-rays already demonstrate osteoarthritis and the symptoms are consistent with osteoarthritis — MRI rarely adds information that changes diagnosis or treatment in this setting, and ordering one only adds wait time and anxiety without benefit.[5] Likewise, arthroscopic debridement should not be used as primary treatment for knee osteoarthritis, since multiple meta-analyses show no maintained benefit over conservative management (exercise therapy, injections, and drugs).[5] For acute trauma, apply the Ottawa Knee Rule (above) as the appropriate decision tool for whether plain radiography is warranted.[4] Ultrasound is not routinely needed except to confirm a suspected tendon rupture or assess a Baker's cyst, and should not delay care while awaited.[1] MRI is reserved for specific situations: an acute injury (under 6 weeks) with a locked knee, suspected osteochondral fracture, multi-ligamentous injury, or suspected posteromedial/posterolateral corner or high-grade MCL injury; a sub-acute injury (6-12 weeks) with persistent swelling/effusion despite an appropriate rehabilitation program, or inability to actively lift and extend the knee against gravity; or a chronic presentation (over 12 weeks) with no osteoarthritis on x-ray, persistent unexplained symptoms for more than 3 months despite a genuine non-operative trial, and the patient both desiring and being medically fit for surgery.[1]

When septic arthritis or gout is suspected

Definitively distinguishing septic arthritis from gout requires synovial fluid analysis by a physician — arthrocentesis with cell count and differential, Gram stain, culture, and crystal examination. A synovial white cell count above roughly 50,000/mm³ with more than 90% neutrophils is most suggestive of a bacterial etiology, though inflammatory gout flares can also reach very high cell counts, so crystal identification (needle-shaped, strongly negatively birefringent monosodium urate crystals in gout) remains essential to the distinction rather than the cell count alone.[3] A pharmacist's role is to recognize that this distinction cannot be made at the counter and to refer promptly rather than recommend OTC gout self-treatment for a hot, swollen knee that has not been assessed.[3]

Treatment Targets

  • Relieve pain and preserve function using the least invasive, appropriately targeted therapy for the likely underlying category.
  • Correctly triage red-flag presentations to prompt medical evaluation rather than trialing OTC self-care.
  • Avoid unnecessary imaging for presentations, particularly degenerative ones, that do not need it for initial management.
  • Support appropriate self-care (activity modification, RICE for acute presentations, structured exercise) as the foundation of management for every non-red-flag category.
  • Select OTC/topical pharmacotherapy appropriate to the presentation, favouring a topical NSAID for localized pain to minimize systemic exposure where appropriate.
  • Recognize when self-care is not working and escalate — to a physician, physiotherapist, or emergency department as appropriate — rather than persisting with an ineffective plan.
  • Avoid duplicating the condition-specific depth already covered in the Osteoarthritis, Sports Injuries, Bursitis, and Gout and Hyperuricemia chapters — direct the patient and prescriber to those chapters once a specific diagnosis is more likely.

Choose Initial Treatment

Direct treatment rule

Every patient — screen for red flags first

Always work through the Red Flags & Referral list before recommending any OTC therapy. Do not recommend OTC self-care for inability to bear weight, significant instability, a hot/swollen/acutely painful joint, suspected fracture per the Ottawa Knee Rule, or any systemic symptom — refer instead.[1][4][3]

No red flags — localized, mild-to-moderate knee pain

1st line activity modification and, for an acute presentation, RICE — see Non-Pharmacologic Management. Topical NSAID first a topical diclofenac product is a reasonable first pharmacologic step for localized knee pain, minimizing systemic NSAID exposure while providing genuine, well-evidenced relief — a Cochrane systematic review of topical NSAIDs in chronic musculoskeletal pain (predominantly knee osteoarthritis) found clinically meaningful pain relief with a number needed to treat of about 5 for topical diclofenac gel/solution overall, with adverse effects limited mostly to local application-site skin reactions rather than the systemic risks of an oral NSAID.[6]

Step up if topical therapy is inadequate

Oral NSAID ibuprofen or naproxen at standard OTC/first-line doses is a reasonable next step, or a reasonable first step where more diffuse pain makes a topical product impractical, weighing the same gastrointestinal, renal, and cardiovascular risk considerations that apply to oral NSAID use generally. Acetaminophen is a reasonable alternative or adjunct where an NSAID is contraindicated or not tolerated, though it does not address an inflammatory component directly.

Patellofemoral pain syndrome specifically

1st line structured exercise targeting hip, trunk, and knee musculature is the cornerstone of treatment, not pharmacotherapy — a program performed roughly three times weekly for six to eight weeks, generally emphasizing posterolateral hip strengthening early and adding knee-focused strengthening as the plan progresses, produces both short- and long-term improvement in pain.[2] Pharmacotherapy (topical or oral NSAID, acetaminophen) is a reasonable adjunct for pain control that allows fuller participation in the exercise program, not a substitute for it. Imaging is not needed for a typical presentation; reserve plain radiographs for pain that has not improved after four to eight weeks of appropriately performed conservative therapy.[2]

Adjunctive topical options with more modest evidence

Capsaicin cream a reasonable adjunct or alternative when a topical NSAID is not tolerated or not preferred, though the evidence is more modest — a 2024 systematic review and meta-analysis found a statistically significant but modest reduction in osteoarthritis pain (including knee-specific benefit) with topical capsaicin versus placebo, rated as very-low-certainty evidence, with an expected local burning sensation as the trade-off.[7] Topical counterirritants (menthol/methyl salicylate combination products) provide a sensory "distraction" effect rather than a genuine anti-inflammatory one; evidence specific to knee pain is limited, and they are a reasonable low-risk option for a patient seeking a non-NSAID topical, but expectations should be set accordingly.

Bursitis, gout, ligament/meniscal injury, and osteoarthritis — direct to the dedicated chapter

Once the pattern points clearly toward one of these four specific conditions, the OTC-level advice above is a reasonable bridge, but definitive management should follow the platform's dedicated chapter for that condition — see Osteoarthritis, Sports Injuries, Bursitis, and Gout and Hyperuricemia.

Non-Pharmacologic Treatment

Activity modification

Modifying, rather than completely avoiding, the specific activity that provokes pain is the foundation of management across every non-red-flag category — complete rest is rarely necessary and can worsen deconditioning and stiffness, particularly for osteoarthritis and patellofemoral pain.

RICE for acute presentations

For an acute knee injury, the classic RICE principles — rest (relative, not complete, rest from the aggravating activity), ice (applied intermittently, for example 15-20 minutes several times daily in the first 24-72 hours), compression (a light elastic wrap or sleeve, avoiding tightness that impairs circulation), and elevation — remain a reasonable, low-risk framework for the first few days after injury.[1] For the more current POLICE-based approach (Protection, Optimal Loading, Ice, Compression, Elevation), which has superseded RICE in the sports medicine literature by emphasizing early, graded loading rather than prolonged rest, see the platform's Sports Injuries chapter.

Appropriate footwear

Supportive, well-cushioned, properly fitted footwear is a reasonable general recommendation, and is specifically relevant to iliotibial band syndrome and patellofemoral pain, where worn-out or inappropriate running shoes are a common contributing factor.

Weight management

For a patient with a BMI over 25 kg/m² and knee pain, weight loss is a genuinely high-yield, evidence-based counselling point, particularly for osteoarthritis and patellofemoral pain — each pound of body weight lost produces roughly a four-fold reduction in the load exerted across the knee per step during daily activities, a concrete and often motivating way to frame the benefit.[1]

Structured exercise and strengthening

Beyond the patellofemoral-specific program above, a structured, active, strength-based physiotherapy program — rather than passive modalities such as ultrasound, TENS, or interferential current, which may give only short-term relief and should not be the focus of treatment — is the evidence-based foundation of non-pharmacologic management across nearly every category in this chapter's differential, generally requiring at least 12 weeks, spaced roughly 1-2 weeks apart, to expect a meaningful functional improvement.[1] Encourage the patient to remain engaged even when early sessions do not produce immediate relief, since fear of movement (kinesiophobia) is a recognized barrier to recovery.[1]

Heat versus ice

Ice is more useful in the acute or sub-acute phase (under 6 weeks) when pain and swelling are the primary issue; heat, applied before activity or exercise, is often more helpful for chronic (over 6 weeks) stiffness-predominant pain, particularly in osteoarthritis.[1]

Bracing and support

An appropriate knee brace or support can be a reasonable adjunct depending on the presentation: a soft, off-the-shelf sleeve or wrap for mild, non-specific knee pain or mild patellofemoral symptoms; an unloading (off-loader) brace for degenerative, one-compartment-predominant osteoarthritis, generally reserved for longer-term (over 6 months) use given cost; and a stabilizing brace following a significant ligamentous injury or for recurrent patellar instability, fitted and recommended in consultation with a physician or physiotherapist rather than selected empirically at the pharmacy counter.[1] Evidence for generic, non-specific knee bracing in mild, undifferentiated knee pain is limited, and a brace should not be framed as a substitute for activity modification and exercise.

Pharmacologic Treatment Options

Drug / interventionRoleDose / useImportant adverse effectsTeaching points
Diclofenac diethylamine (topical gel)
Preferred
1st-line pharmacologic step for localized knee pain, minimizing systemic NSAID exposureApply to the skin over the affected area 3-4 times daily (per product labelling; do not exceed the labelled maximum daily amount)Local application-site skin irritation; systemic effects uncommon at topical dosesNumber needed to treat of about 5 for clinically meaningful pain relief in knee osteoarthritis; better systemically tolerated than an oral NSAID.
Ibuprofen
Alternative
Oral NSAID if topical therapy is inadequate or pain is more diffuse200-400 mg PO every 4-6 hours PRN (OTC), maximum 1200 mg/day OTCGI upset/bleeding, renal impairment, cardiovascular riskTake with food; use the lowest effective dose for the shortest duration.
Naproxen
Alternative
Oral NSAID alternative to ibuprofen with a longer duration of action220 mg PO every 8-12 hours PRN (OTC), maximum 440 mg/day OTCGI upset/bleeding, renal impairment, cardiovascular riskTake with food; useful when twice-daily dosing supports adherence.
Acetaminophen
Alternative
Analgesia when an NSAID is contraindicated or not tolerated, or added for additional pain control325-1000 mg PO every 6 hours PRN, maximum 4 g/day (lower in hepatic impairment)Hepatotoxicity with overdose or in significant hepatic impairmentDoes not address an inflammatory component; reasonable alone or combined with a topical NSAID.
Capsaicin cream (0.025-0.075%)
Special situation
Adjunct or alternative when a topical NSAID is not tolerated or not preferredApply to the affected area 3-4 times daily; consistent regular use (not PRN) is needed for benefitLocal burning/stinging, usually most pronounced in the first few days and improving with continued regular useModest, very-low-certainty evidence of benefit; warn about expected initial burning to support adherence; wash hands after application.
Topical counterirritant (menthol / methyl salicylate)
Alternative
Non-NSAID topical option based on patient preferenceApply to the affected area up to 3-4 times daily per product labellingLocal skin irritation, warming/cooling sensation; do not use with a heating pad or occlusive dressingEvidence specific to knee pain is limited; provides symptomatic sensory relief rather than a genuine anti-inflammatory effect.

Special Populations

Pregnancy

Favor non-pharmacologic measures (activity modification, RICE, structured exercise) throughout pregnancy. Preferred analgesic acetaminophen. Avoid NSAIDs (oral or topical) from approximately 20 weeks of pregnancy onward Health Canada has confirmed a risk of fetal renal impairment and low amniotic fluid (oligohydramnios) with NSAID use from about 20 weeks, and NSAIDs are contraindicated in the third trimester (beyond 28 weeks) for this reason.[8] A new or worsening hot, swollen, or significantly painful knee in pregnancy should still be referred promptly — the same septic arthritis/gout red flag applies.

Breastfeeding

Acetaminophen and ibuprofen are considered compatible with breastfeeding; topical NSAID and topical capsaicin products carry minimal systemic absorption and are reasonable options as well.

Pediatrics and adolescents

Patellofemoral pain syndrome is common in this age group, particularly in adolescent girls.[2] Osgood-Schlatter disease — pain and tenderness at the tibial tubercle, worse with activity (running, jumping) and better with rest, typically during a growth spurt — is a distinct and generally self-limiting pediatric-specific cause of anterior knee pain; topical or weight/age-appropriately-dosed oral NSAIDs and activity modification are the mainstay, and it typically resolves once growth is complete, though physiotherapy can help guide the patient if secondary issues develop.[1] Avoid acetylsalicylic acid (aspirin) in children and adolescents with a viral illness given the risk of Reye syndrome. Any atypical pediatric presentation — a limp without a clear mechanical cause, a fixed flexion deformity, or systemic symptoms — should prompt referral rather than an assumption of a benign growth-related cause.

Older adults

Osteoarthritis becomes progressively more likely as the primary cause of knee pain with age (classically over 50), and the Ottawa Knee Rule specifically flags age 55 years or older as one criterion favouring x-ray after acute trauma, reflecting a lower threshold for occult fracture in this group.[4] Favor a topical NSAID, topical capsaicin, or acetaminophen over an oral NSAID where possible, given higher baseline gastrointestinal, renal, and cardiovascular risk with systemic NSAID use in older adults; if an oral NSAID is genuinely needed, use the lowest effective dose for the shortest duration.

Renal and hepatic impairment

Avoid or dose-reduce oral NSAIDs in significant renal impairment; a topical NSAID has substantially lower systemic absorption and is a reasonable preferred option here, though it is not entirely risk-free and caution is still warranted with extensive use. Reduce the acetaminophen total daily dose in significant hepatic impairment.

Monitoring & Follow-Up

For an acutely swollen knee injury being followed conservatively, reassess roughly every 2 weeks until a clear diagnosis and trajectory are established.[1] For most knee complaints appropriate for conservative/OTC management, clear improvement should be seen within 6-12 weeks; schedule or encourage follow-up within that window specifically to reassess symptoms and functional progress and to re-evaluate the working diagnosis if improvement is not being seen.[1] For patellofemoral pain syndrome specifically, an exercise program needs a genuine 6-8 week trial performed consistently (roughly three times weekly) before its effect can be fairly judged.[2] At every follow-up, re-screen for the red flags above — a presentation that seemed benign initially can evolve, and new instability, swelling, or systemic symptoms should prompt reassessment regardless of how much time has passed since the original visit.

Treatment Failure / Next Step

  1. Re-screen explicitly for red flags before assuming simple treatment failure — a missed ligament/meniscal injury, an evolving septic or gout process, or an occult fracture are more consequential explanations than inadequate OTC dosing.
  2. Confirm the conservative trial was genuine and adequate: correct topical/oral NSAID technique and adherence, real activity modification, and, where relevant, a structured exercise program performed consistently for the expected 6-12 week window (6-8 weeks specifically for patellofemoral pain).
  3. If pain is not improving despite an adequate topical NSAID trial, step up to an oral NSAID (or combine both if not already done, respecting maximum daily NSAID exposure across formulations).
  4. Persistent effusion or swelling despite an appropriate 6-week rehabilitation program, or inability to actively lift and extend the knee against gravity, is a specific threshold for reconsidering imaging (MRI) and referral rather than continuing the same conservative plan indefinitely.
  5. A chronic presentation (over 12 weeks) with no osteoarthritis on x-ray, persistent unexplained pain, instability, or giving-way for more than 3 months despite a genuine non-operative trial, in a patient who desires and is medically fit for surgery, is a reasonable threshold to discuss MRI and orthopedic or sports medicine referral.
  6. Suspected patellofemoral pain syndrome not improving after four to eight weeks of appropriately performed conservative therapy: this is the specific point at which plain radiographs become reasonable, since imaging was not indicated at the outset.
  7. Once a specific diagnosis becomes clear or likely (osteoarthritis, an acute ligament/meniscal injury, bursitis, or gout), transition the patient to the platform's dedicated chapter for that condition rather than continuing indefinitely with generic knee-pain-level advice.

Common Errors to Avoid

  • Recommending OTC self-care for a hot, swollen, acutely painful knee without first ensuring the patient has been assessed to exclude septic arthritis — this distinction cannot be made reliably at the pharmacy counter.[3]
  • Treating every case of knee pain as osteoarthritis by default in an older patient, without considering an acute injury, gout, or another cause that changes the management plan.
  • Missing "true locking" or "true giving way" by not asking about them specifically — patients often describe these imprecisely as stiffness or weakness unless asked directly.[1]
  • Reinforcing an MRI referral for straightforward degenerative knee pain when weight-bearing x-rays already show osteoarthritis consistent with the symptoms — this rarely changes management and only adds delay.[5]
  • Overlooking patellofemoral pain syndrome in a younger, active patient with anterior knee pain, and reflexively recommending rest instead of a structured hip/knee strengthening program, which is the actual first-line, evidence-based treatment.[2]
  • Recommending prolonged, complete rest for chronic or overuse-pattern knee pain rather than activity modification and structured exercise, which delays recovery and worsens deconditioning.
  • Selecting a generic OTC recommendation without first sorting the presentation into one of the six categories in this chapter's framework — the right topical/oral choice and self-care advice genuinely differs by category.
  • Forgetting that a topical NSAID is a genuinely well-evidenced first-line option for localized knee pain, and reflexively recommending an oral NSAID or acetaminophen instead without considering it.[6]
  • Applying a topical counterirritant or capsaicin product under an occlusive dressing or with a heating pad, risking thermal or chemical burns.
  • Duplicating deep, condition-specific content that already exists in the Osteoarthritis, Sports Injuries, Bursitis, or Gout and Hyperuricemia chapters instead of triaging the patient toward that chapter once the likely diagnosis is clear.

Clinical Decision Algorithm

Algorithm A — Red-flag triage
Patient presents with knee pain
Screen for red flags: inability to bear weight/instability, hot+swollen+acutely painful joint, significant trauma, systemic symptoms, neurovascular compromise, true locking[1]
Red flag present
Refer for prompt medical evaluation — do not recommend OTC self-care[3][4]
No red flags
Proceed to Algorithm B — sort into a practical category
Algorithm B — Sorting non-red-flag knee pain into a practical category
No red flags identified — sort by history and pain pattern
Age over 50, activity pain + inactivity stiffness, diffuse joint-line ache, stable ligaments
Likely degenerative (osteoarthritis) — see the Osteoarthritis chapter[1]
Anterior knee pain, worse with stairs/squatting/prolonged sitting, younger or active patient, normal ROM
Likely patellofemoral pain syndrome — structured hip/knee exercise program is 1st line[2]
Discrete traumatic event, true locking or true giving way, rapid swelling/bruising
Likely acute ligament/meniscal injury — apply the Ottawa Knee Rule; see the Sports Injuries chapter[4]
Localized swelling after kneeling (prepatellar), or medial pain with valgus strain (pes anserine)
Likely bursitis — see the Bursitis chapter
Acute monoarticular swelling, prior similar episodes, risk factors (diuretics/alcohol/purine intake)
Consider gout — confirm no red flag (hot/acutely painful joint) present, then see the Gout and Hyperuricemia chapter[3]
Gradual-onset activity-related pain over a specific tendon or the lateral femoral condyle, no swelling
Likely tendinopathy or iliotibial band syndrome — activity modification and structured exercise
Target OTC/topical therapy and self-care advice to the likely category — proceed to Algorithm C
Algorithm C — OTC pharmacologic escalation
Localized, mild-to-moderate knee pain, no red flags
1st line: activity modification +/- RICE (acute), plus a topical NSAID for localized pain[6]
Adequate response
Continue; reinforce activity modification and, where relevant, structured exercise
Inadequate response after a genuine trial
Step up to an oral NSAID or acetaminophen; consider capsaicin or a topical counterirritant as an alternative
Improving within 6-12 weeks (4-8 weeks for patellofemoral pain)
Continue; taper as symptoms allow
Not improving, new red flag, or persistent effusion/functional limitation
Refer for medical reassessment and imaging per the thresholds in Assessment & Diagnosis[1]

Drug Tables

How to use this table: doses are adult, OTC/first-line doses and require patient-specific confirmation, including renal/hepatic adjustment. Select any drug name to open its complete Pharmasist Drug Database page.

Topical Analgesics — Preferred First Step for Localized Knee Pain

Doses below are adult doses and require patient-specific confirmation. Topical products minimize systemic exposure compared with an oral NSAID and are a reasonable first pharmacologic step for pain localized to the knee itself.

DrugDosageAdverse effectsDrug interactionsComments
Diclofenac diethylamine
Adults: Apply to the skin over the affected area 3-4 times daily
Local application-site skin irritation; systemic effects uncommon at topical dosesMinimal systemic interaction risk at topical doses1st-line topical option; number needed to treat of about 5 for clinically meaningful pain relief in knee osteoarthritis.
Capsaicin
Adults: Apply to the affected area 3-4 times daily
Local burning/stinging, usually most pronounced in the first few days and improving with continued regular useNone significant at topical dosesModest, very-low-certainty evidence; consistent regular (not PRN) use is needed for benefit; wash hands after application.
Topical counterirritant (menthol / methyl salicylate)
Adults: Apply to the affected area up to 3-4 times daily per product labelling
Local skin irritation, warming/cooling sensationNone significant at topical dosesEvidence specific to knee pain is limited; do not use with a heating pad or an occlusive dressing.

Oral Analgesics and NSAIDs

Doses below are adult, OTC/first-line doses and require patient-specific confirmation, including renal/hepatic adjustment and maximum daily NSAID exposure across all formulations used concurrently.

DrugDosageAdverse effectsDrug interactionsComments
Ibuprofen
Adults: 200-400 mg PO every 4-6 hours PRN, maximum 1200 mg/day OTC
GI upset/bleeding, renal impairment, cardiovascular riskIncreased bleeding risk with anticoagulants/antiplatelets; avoid combining with another NSAIDTake with food; use the lowest effective dose for the shortest duration.
Naproxen
Adults: 220 mg PO every 8-12 hours PRN, maximum 440 mg/day OTC
GI upset/bleeding, renal impairment, cardiovascular riskIncreased bleeding risk with anticoagulants/antiplatelets; avoid combining with another NSAIDTake with food; twice-daily dosing may support adherence.
Acetaminophen
Adults: 325-1000 mg PO every 6 hours PRN, maximum 4 g/day (lower in hepatic impairment)
Hepatotoxicity with overdose or in significant hepatic impairmentNone significant at standard dosesReasonable alone or combined with a topical NSAID; does not address an inflammatory component.

References

  1. Provincial Knee Primary Care Clinical Pathway — Primary Care Alberta / Alberta Health Services (Page J, Sargious M, co-design leads). Alberta Health Services clinical pathway, updated January 2026
  2. Patellofemoral Pain Syndrome — American Family Physician (Gaitonde DY, Ericksen A, Robbins RC). Am Fam Physician 2019;99(2):88-94
  3. Acute Monoarthritis: Diagnosis in Adults — American Family Physician (Becker JA, Daily JP, Pohlgeers KM). Am Fam Physician 2016;94(10):810-816
  4. Prospective validation of a decision rule for the use of radiography in acute knee injuries — JAMA (Stiell IG, Greenberg GH, Wells GA, et al.). JAMA 1996;275(8):611-615
  5. Orthopaedics: Ten Things Physicians and Patients Should Question — Choosing Wisely Canada, Canadian Orthopaedic Association / Canadian Arthroplasty Society / Arthroscopy Association of Canada. Choosing Wisely Canada, last updated February 2018
  6. Topical NSAIDs for chronic musculoskeletal pain in adults — Cochrane Database of Systematic Reviews (Derry S, Conaghan P, Da Silva JAP, Wiffen PJ, Moore RA). Cochrane Database Syst Rev 2016;4:CD007400
  7. Efficacy and safety of topical capsaicin in the treatment of osteoarthritis pain: A systematic review and meta-analysis — Phytotherapy Research (Tshering G, Posadzki P, Kongkaew C). Phytother Res 2024;38(7):3695-3705
  8. Advisory: Use of non-steroidal anti-inflammatory drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage in unborn babies, leading to low amniotic fluid — Health Canada. Health Canada Public Advisory, October 2020 (labelling update June 2021)

Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.